An Indian scientist works inside a laboratory of the Research and Development Centre of Natco Pharma Ltd. in Hyderabad, India, Tuesday, March 13, 2012. India effectively ended Bayer's monopoly on a patented cancer drug Monday, licensing a much cheaper generic under a unique law aimed at keeping costs affordable. In a decision likely to upset Western pharmaceuticals, the patent office approved Natco Pharma Ltd.'s application to produce the kidney and liver cancer treatment sorefinib.

An Indian scientist works inside a laboratory of the Research and Development Centre of Natco Pharma Ltd. in Hyderabad, India, Tuesday, March 13, 2012. India effectively ended Bayer's monopoly on a patented cancer drug Monday, licensing a much cheaper generic under a unique law aimed at keeping costs affordable. In a decision likely to upset Western pharmaceuticals, the patent office approved Natco Pharma Ltd.'s application to produce the kidney and liver cancer treatment sorefinib.

Generic drugs account for 80 percent of the pharmaceuticals prescribed to Americans. Why they’re cheaper and who’s responsible when something goes wrong.

Guests

  • Katie Thomas reporter, New York Times
  • Steven Brill journalist and author of "Bitter Pill: How outrageous pricing and egregious profits are destroying our health care," a special report for Time Magazine's March 4, 2013, edition.
  • Dr. Sidney Wolfe director of the Health Research Group at Public Citizen; editor of WorstPills.org
  • Ralph Neas president and ceo, Generic Pharmaceutical Association

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

Friday News Roundup – International

Friday, Apr 17 2015Iran's president accuses the U.S. Congress of meddling in the nuclear deal. The White House will remove Cuba from the terrorism-sponsor list. And Europe files an anti-trust case against Google. A panel of journalists joins Diane for analysis of the week's top international news stories.

Friday News Roundup – Domestic

Friday, Apr 17 2015The 2016 presidential campaign begins in earnest. National protests for a $15 minimum wage heat up. And Boston marks the two-year anniversary of the marathon bombings. A panel of journalists joins Diane for analysis of the week's top national news stories.

David Brooks: “The Road To Character”

Thursday, Apr 16 2015New York Times Columnist David Brooks says American culture’s obsession with individual achievement and self-worth has gone too far. In a new book, he argues it is time to rethink what makes a fulfilling life and become more humble, kind and self-sacrificing.

The First Hundred Days Of The Republican-Led Congress

Thursday, Apr 16 2015Congress has reached agreement on oversight of the Iran nuclear deal and a Medicare "doc fix," and is working on fast-track trade authority for President Barack Obama. A hundred days into the new Republican-led Congress, we look at what’s been accomplished and what’s to come.